4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-23-050863
Chief Financial Officer sold 294 shares at $8.38 ($2,464)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas Chief Financial Officer | 2023-09-27 | Sale | −294 | $8.38 | $2,464 | 145,842 | D |
| Open-market sales · 294 sh · avg $8.38 · $2,464 | |||||||
Loading xslF345X05/doc4.xml…